Shares of DocGo Inc. (NASDAQ:DCGO – Get Free Report) have been assigned a consensus rating of “Buy” from the five ratings firms that are presently covering the firm, MarketBeat Ratings reports. Five analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $10.83.
A number of equities analysts recently commented on DCGO shares. Cantor Fitzgerald cut their price objective on DocGo from $13.00 to $11.00 and set an “overweight” rating on the stock in a research note on Thursday, February 29th. Stifel Nicolaus dropped their price target on DocGo from $11.00 to $8.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Needham & Company LLC dropped their price target on DocGo from $14.00 to $10.00 and set a “buy” rating on the stock in a research note on Thursday, February 29th. Canaccord Genuity Group dropped their price target on DocGo from $10.00 to $9.00 and set a “buy” rating on the stock in a research note on Thursday, April 11th. Finally, BTIG Research dropped their price target on DocGo from $13.00 to $11.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th.
View Our Latest Research Report on DCGO
Insider Activity
Institutional Investors Weigh In On DocGo
Several institutional investors have recently bought and sold shares of the stock. Pasadena Private Wealth LLC grew its holdings in DocGo by 363.6% during the first quarter. Pasadena Private Wealth LLC now owns 395,487 shares of the company’s stock worth $1,598,000 after buying an additional 310,180 shares in the last quarter. Vanguard Group Inc. grew its holdings in DocGo by 2.8% during the fourth quarter. Vanguard Group Inc. now owns 4,804,845 shares of the company’s stock worth $26,859,000 after buying an additional 132,263 shares in the last quarter. Wolverine Trading LLC grew its holdings in DocGo by 502.7% during the fourth quarter. Wolverine Trading LLC now owns 10,369 shares of the company’s stock worth $58,000 after buying an additional 12,944 shares in the last quarter. Nuveen Asset Management LLC grew its holdings in DocGo by 23.8% during the fourth quarter. Nuveen Asset Management LLC now owns 505,877 shares of the company’s stock worth $2,828,000 after buying an additional 97,189 shares in the last quarter. Finally, Birchview Capital LP grew its holdings in DocGo by 15.4% during the fourth quarter. Birchview Capital LP now owns 150,000 shares of the company’s stock worth $838,000 after buying an additional 20,000 shares in the last quarter. Institutional investors own 56.44% of the company’s stock.
DocGo Trading Up 1.8 %
Shares of DCGO stock opened at $3.42 on Friday. The business’s 50-day moving average price is $3.73 and its 200-day moving average price is $4.65. The firm has a market capitalization of $356.26 million, a price-to-earnings ratio of 48.86, a PEG ratio of 0.34 and a beta of 0.91. DocGo has a 12 month low of $2.78 and a 12 month high of $10.82.
DocGo (NASDAQ:DCGO – Get Free Report) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.06 EPS for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.07). The company had revenue of $199.25 million during the quarter, compared to analyst estimates of $195.48 million. DocGo had a return on equity of 2.01% and a net margin of 1.10%. On average, sell-side analysts predict that DocGo will post 0.35 earnings per share for the current fiscal year.
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Stories
- Five stocks we like better than DocGo
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Comprehensive PepsiCo Stock Analysis
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Where Do I Find 52-Week Highs and Lows?
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.